BSD Medical is Now Pyrexar Medical

The complete line of BSD Hyperthermia products are availble thru Pyrexar Medical

Part 5 of the ABC news series on hyperthermia is probably the most important.  In the past, we have talked about phase III clinical studies, and have shown peer-reviewed evidence that adding hyperthermia to radiotherapy and chemotherapy improves outcomes and extends life. We know it energizes the bodies immune system to fight the cancer on its own.  We know it is well excepted as a cancer treatment in Europe and Asia.

But none of that matters. No matter how effective hyperthermia treatment is, it will not save your mother, your father, sister, brother, aunt, uncle, grandmother, grandfather or your child, if it remains relatively unknown in the U.S.  Whether you know it or not, you have a choice in your medical treatment.  It takes research and advocacy and the sharing of information. In this news series, you met four people who are here today because someone advocated for them and for hyperthermia.

You can help more people survive cancer. Share this story. Shed some light that there are hyperthermia treatment protocols for most cancers that have solid tumors. Tell people that hyperthermia was once an ancient medical treatment, or that it uses some of the most advanced image-guided technology in medicine. Tell them there are 30 years of scientifically proven evidence, it has FDA approval, its available in university hospitals and cancer centers in this country and can be covered by insurance.  Tell them there is a map that will show them where the closest center is located. It is that simple.

why abc part 5 2018 key

See the video and full transcript at www.Good4Utah.com

Thank you to all of the generous individuals that were involved in making this story happen.  Thank you to the ABC Good4Utah news team for taking on topics that help others.  To Gamma West Cancer Services for not backing away from patients that others have given up on.  And to my co-workers at Pyrexar Medical, particularly Paul Turner, who continues to improve this technology, and has for over 40 years. Thank you.

See the complete ABC News series Part 1Part 2Part 3Part 4Part 5

 

We just returned from Taiwan after attending the TASTRO -  Taiwan Society for Therapeutic Radiology and Oncology annual conference.  The event was held at the Tiangong Hall in the Kaohsiung Junhong Hotel in  Kaohsiung City. Presenters at the two day conference covered a range of topics including the Best of ASTRO topics (Head and Neck Cancer, Abdomen/Pelvis, Chest).  We also enjoyed the presentation on the use of brachytherapy in early stage breast cancer. We believe that interstitial hyperthermia, and the immune response trigger of heat, can play an important role in this treatment protocol. But the main focus of the event centered around proton therapy.

Dr. Zeljko Vujaskovic presented "Thermal Therapy in Cancer Treatment" as the keynote speaker of the event.

Univ. of Maryland Featured Speaker
Taiwan Society for Therapeutic Radiation Oncology Annual Conference
Ames Medical Represents Pyrexar

Our sales agent for Taiwan, Ames Medical, put together an excellent booth presentation for the Pyrexar product line

previous arrow
next arrow
Slider

The highlight of the conference was a keynote presentation by Dr. Zeljko Vujaskovic from the University of Maryland Proton Center. Dr. Vujaskovic provided an overview of the development of Thermal Therapy, with an emphasis on its reemerging role in cancer treatment.   Dr. Vujaskovic and his team have developed the world's first center to combine proton therapy and  thermal therapy treatment in a single facility. The team has recently started treating patients in the new thermal suite and early results are positive.  The University of Maryland has used the BSD-500 for many years and the recent addition of a BSD-2000 last spring will allow them to treat cases using hyperthermia in the superficial, interstitial, and deep regional modes.

AmesLOGOA special thanks to our Taiwan sales organization AMES Medical. They did a tremendous job hosting our team and creating a comprehensive marketing and sales presentation in the conference booth.


Plus: AIRO - Italian Association of Radiotherapy Oncology

TemaSinergie 250pxWe were also represented this month at the AIRO by our distributor Tema Sinergia. The 28th Annual AIRO was held Nov. 2-4 at the Rimini Conference Center, Rimini, Italy. The event is co-located with the 31st National Congress AIRB and the 10th National AIRO Youth Congress.

AIRO 2018

Thank you to the Tema Sinergia team for their great work.

We just returned from the 60th Annual ASTRO in San Antonio, Texas and wanted to share our experience. First, it was a great show for Pyrexar. We had immediate traffic in the booth and for the first time we did not have to explain the benefits of hyperthermia as a drug-free radiosensitizer or hyperthermia’s role as an immune modulator. Second, the recent announcement from the University of Maryland Proton Center of its new BSD-2000 hyperthermia suite and the follow-up article in DotMED.com created an immediate draw to the booth.

previous arrow
next arrow
Slider
 
The theme of this year's booth centered squarely on the advances of image guided thermal therapy and the BSD-2000 3D/MR, shown in the featured booth graphic, with hands on access to the Sigma Eye/MR Applicator and the newly redesigned Sigma 30 for the BSD-2000 and BSD-2000 3D/MR. The Sigma 30 is a 30cm applicator designed for limbs (soft tissue sarcoma) and pediatric applications.

The crowds and the physical space was about 20% smaller this year.  The quality of the show still maintained its excellence as an important platform for scientific review and new product introductions. Many of the large radiation equipment manufacturers focused more on software than hardware.

Stopping by the booth were hyperthermia luminaries, Dr. Zeljko Vujaskovic from University of Maryland, Dr. Mark Hurwitz from Thomas Jefferson Sidney Kimmel Cancer Center and Dr. Niloy Datta, Kantonsspital Aarau, Switzerland. Dr. Datta presented a poster titled "Therapeutic Options for Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-analysis" at the new ASTRO Digital Poster Pavilion.

We would also like to thank our partners Sennewald Medizintechnik (Germany/Europe/Russia) for their participation in the booth.  As well as Orientech (China); Tema Sinergie (Italy); Hanbeam Technology (South Korea) and our newest partners Sukosol (Thailand) and HuaLong BioMed (Taiwan), for bringing in a constant flow of prospects from around the globe.

Next stop is the 2018 Taiwan Radiation Oncology Annual Symposium sponsored by TASTRO - Taiwan Society for Therapeutic Radiation Oncology, held in Kaohsiung City, Taiwan Nov. 10 - 11. Our Taiwan partner Ames Medical will have a booth and Dr. Zeljko Vujaskovic is a featured speaker presenting his work in hyperthermia and its role in proton therapy.

zjelko at umm

In an announcement this week, the University of Maryland's Proton Center has established the world's first combined Hyperthermia/Proton Beam therapy center. The therapy suite features the BSD-2000 Deep Regional Hyperthermia system as a complement to the center's 122,000 sq. ft., five bay, $270M, Varian ProBeam Proton system.

See Announcement: High-Precision Proton Therapy More Effective in Treating Certain Cancers When Combined with Thermal Therapy

Proton therapy is a precise form of radiation for the treatment of solid, localized tumors. Unlike X-ray (photon) technology, protons deliver a maximum radiation dose that stops at the tumor site. This enables our physicians to target the cancer cells with millimeter precision while sparing normal, healthy surrounding tissue in the rest of your body.

Hyperthermia, as an adjunct therapy, is expected to provide the same functionality as it would for traditional radiotherapy by increasing tumor oxygenation; boosting effective dose by 150%; preventing DNA repair to damaged cancer cells and by awakening the bodies immune system to the identify and destroy cancer.  The big difference is the belief that Hyperthermia + Proton = Carbon Ion as theorized in a paper Could hyperthermia with proton therapy mimic carbon ion therapy? by Dr. Niloy Datta.

This is an exciting advancement for hyperthermia to the forefront of cancer treatment.

More: Maryland Proton Treatment Center combines hyperthermia with proton therapy